PROCEPT Q2 revenue $94.5M (+19% YoY); net loss $26.9M; reiterates FY guidance

PROCEPT BioRobotics Corp

Revenue $94.5M, up 19% YoY; U.S. procedures over 13,100 (+21% YoY).
Net loss $26.9M vs $19.6M loss in Q2 2025; adjusted EBITDA loss $11.3M vs $8.0M.
Delivered 65 U.S. HYDROS systems (14 replacements); handpiece ASP $3,550 (+11% YoY).
Gross margin 66% (65% prior year) including $2.9M tariff refund; cash $231M.
FY 2026 revenue guidance reiterated $390-410M; now expects U.S. procedures 54,000-56,000.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.